The Ann Arbor Staging System is a standardized method used to classify the extent and spread of cancer, specifically lymphomas. It was first introduced in 1971 and has since been a critical tool for oncologists to determine the stage of Hodgkin lymphoma and non-Hodgkin lymphoma. The system is essential for designing treatment plans and predicting patient outcomes.